
|Videos|November 6, 2020
Testosterone therapy does not appear to worsen outcomes in men with COVID-19
Author(s)Urology Times staff
Amarnath Rambhatla, MD, discusses findings from a study published online in the Journal of Sexual Medicine.
Advertisement
In this interview, Amarnath Rambhatla, MD, discusses findings from the Journal of Sexual Medicine study, COVID-19 infection in men on testosterone therapy, for which he served as a study author. Rambhatla is director of men’s health at the Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
More videos:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5









